Microperimetry and Structural Risk Factors on OCT in Intermediate Age-Related Macular Degeneration
Ophthalmology Retina · 2024
DOI: 10.1016/j.oret.2024.02.016 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Alexander Kai Thomsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark; Faculty of Health and Medical Sciences, …. Hauptthemen laut MEDLINE: Macular Degeneration, Visual Fields. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Velux Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark; Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen,…
- Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.
Förderung
- Velux Foundation
Zitieren
APA
Thomsen, A. K., Gøttsche, L. F., Hinnerskov, J. M. V., Falk, M. K., & Sørensen, T. L. (2024). Microperimetry and Structural Risk Factors on OCT in Intermediate Age-Related Macular Degeneration. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.02.016
Vancouver
Thomsen AK, Gøttsche LF, Hinnerskov JMV, Falk MK, Sørensen TL. Microperimetry and Structural Risk Factors on OCT in Intermediate Age-Related Macular Degeneration. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.02.016
BibTeX
@article{Thomsen2024,
author = {Thomsen, Alexander Kai and Gøttsche, Liselotte Fribo and Hinnerskov, Jenni Martinez Villarruel and Falk, Mads Krüger and Sørensen, Torben Lykke},
title = {Microperimetry and Structural Risk Factors on OCT in Intermediate Age-Related Macular Degeneration},
journal = {Ophthalmology Retina},
year = {2024},
doi = {10.1016/j.oret.2024.02.016}
}
EUVIMED